|
ZNF260 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.755300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.177200E-03 |
| Normal-vs-Stage2 |
1.492010E-01 |
| Normal-vs-Stage3 |
2.303600E-02 |
| Normal-vs-Stage4 |
3.281500E-03 |
| Stage1-vs-Stage2 |
8.333800E-01 |
| Stage1-vs-Stage3 |
6.148400E-01 |
| Stage1-vs-Stage4 |
3.668600E-01 |
| Stage2-vs-Stage3 |
8.661200E-01 |
| Stage2-vs-Stage4 |
5.696600E-01 |
| Stage3-vs-Stage4 |
5.752200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.675900E-03 |
| Normal-vs-AfricanAmerican |
2.487500E-02 |
| Normal-vs-Asian |
2.511700E-02 |
| Caucasian-vs-AfricanAmerican |
8.277200E-01 |
| Caucasian-vs-Asian |
5.792200E-01 |
| AfricanAmerican-vs-Asian |
5.968800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.039900E-04 |
| Normal-vs-Female |
7.483400E-01 |
| Male-vs-Female |
8.481100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.570200E-02 |
| Normal-vs-Extreme_Weight |
7.97780000000303E-05 |
| Normal-vs-Obese |
4.130200E-01 |
| Normal-vs-Extreme_Obese |
1.380210E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.944000E-01 |
| Normal_Weight-vs-Obese |
2.077600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.566800E-01 |
| Extreme_Weight-vs-Obese |
2.246400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.686400E-01 |
| Obese-vs-Extreme_Obese |
3.954800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.996800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.948030E-01 |
| Normal-vs-Age(61-80Yrs) |
1.382960E-03 |
| Normal-vs-Age(81-100Yrs) |
1.096080E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.735800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.736200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.140380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.491600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.783500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.255200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.784400E-02 |
| Normal-VS-Type2 PRCC |
1.609050E-04 |
| Normal-VS-KIRP CIMP |
3.912600E-01 |
| Normal-VS-Unclassified PRCC |
4.533400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.478700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.166600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.098200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.668200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.156000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.150600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.97934999999205E-05 |
| Normal-vs-N1 |
9.301000E-01 |
| Normal-vs-N2 |
2.00449999999686E-05 |
| N0-vs-N1 |
1.740320E-02 |
| N0-vs-N2 |
9.715600E-02 |
| N1-vs-N2 |
5.7419000000003E-05 |
|
|
